Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), D1, Vasantkunj, New Delhi, 110070, India.
Department of Clinical Hematology, Command Hospital (Eastern Command), Kolkata, India.
Hepatol Int. 2015 Oct;9(4):627-39. doi: 10.1007/s12072-015-9653-x. Epub 2015 Sep 2.
The current definitions of acute kidney injury (AKI) including HRS have been derived from patients with decompensated cirrhosis. No studies have carefully addressed AKI in patients with acute on chronic liver failure (ACLF). We evaluated the prevalence, spectrum, natural history and mortality of AKI at admission and new-onset AKI in hospitalized patients with ACLF and compared the results with patients with acute decompensation of cirrhosis (ADC).
Consecutive patients with ACLF (n = 382) and ADC (n = 451) were prospectively studied. Serial renal and liver functions were recorded and correlated with the disease course and outcome.
AKI at admission and new onset AKI in the hospital were not different in patients with ACLF and ADC (p > 0.05). However, a significant difference in the spectrum of AKI was noted; functional volume-responsive AKI was more common (p < 0.05) in ADC, while patients with ACLF more frequently had the structural form of AKI (p < 0.05). Moreover, patients with ADC had significantly less AKI progression (p < 0.05) and prolonged duration (p < 0.05), a lower requirement of RRT (p < 0.05) and also less AKI resolution (p < 0.05) compared to ACLF patients. Patients with ACLF (versus ADC) had a significantly higher mortality on multivariate analysis.
The kidneys are differentially affected in patients with cirrhosis with or without liver failure. Patients with ACLF with AKI have more structural AKI, greater potential for reversibility despite higher progression as well as higher mortality compared to patients with ADC. Prevention and early detection of AKI should be considered in patients with ACLF.
目前的急性肾损伤(AKI)定义包括 HRS,这些定义是从失代偿性肝硬化患者中得出的。没有研究仔细探讨过慢性肝衰竭急性加重(ACLF)患者的 AKI。我们评估了住院 ACLF 患者入院时和新发 AKI 的患病率、谱、自然史和死亡率,并将结果与急性失代偿性肝硬化(ADC)患者进行了比较。
前瞻性研究了连续的 ACLF(n = 382)和 ADC(n = 451)患者。记录了连续的肾功能和肝功能,并与疾病过程和结果相关联。
ACLF 和 ADC 患者的入院时 AKI 和医院内新发 AKI 无差异(p > 0.05)。然而,AKI 的谱存在显著差异;功能容量反应性 AKI 在 ADC 中更为常见(p < 0.05),而 ACLF 患者更常出现 AKI 的结构性形式(p < 0.05)。此外,ADC 患者的 AKI 进展(p < 0.05)和持续时间(p < 0.05)显著缩短,RRT 的需求(p < 0.05)显著降低,AKI 缓解率(p < 0.05)也较低。多变量分析显示,ACLF 患者的死亡率显著高于 ADC 患者。
肝脏衰竭患者的肾脏受到不同程度的影响。与 ADC 患者相比,ACLF 合并 AKI 的患者具有更多的结构性 AKI,尽管进展更大,但逆转的潜力更大,死亡率更高。应考虑在 ACLF 患者中预防和早期发现 AKI。